The FDA has approved phentolamine ophthalmic solution (Ryzumvi) 0.75% for treatment-induced mydriasis, Viatris and Ocuphire Pharma announced. The approval stipulates use of the eye drops to manage ...
Viatris Inc. VTRS and partner Ocuphire Pharma, Inc. OCUP together announced the FDA approval of Ryzumvi (phentolamine ophthalmic solution) 0.75% to treat pharmacologically-induced mydriasis produced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback